首頁 › 癌症（所有類型） › 德克薩斯州 › Houston
Houston, TX 的 癌症（所有類型） 臨床試驗
121 項針對 癌症（所有類型） 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
招募中2/3 期
- The University of Texas MD Anderson Cancer Center /ID# 275107, Houston
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
招募中1 期
- The University of Texas - MD Anderson Cancer Center, Houston
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, Houston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
招募中觀察性研究
- The University of Texas M.D. Anderson Cancer Center, Houston
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
招募中1 期
- MD Anderson Cancer Center, Houston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
招募中3 期
- Investigative Site, Houston
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
招募中2 期
- Baylor College of Medicine Medical Center ( Site 0004), Houston
- Harris Health System ( Site 0040), Houston
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
招募中1 期
- MD Anderson Cancer Center, Houston
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
招募中1/2 期
- University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- Houston Methodist Hospital, Houston
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
招募中1 期
- MD Anderson Cancer Center, Houston
A Study of JNJ-1761981 in Participants With Solid Tumors
招募中1 期
- MD Anderson Cancer Center, Houston
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
招募中3 期
- Oncology Consultants PA, Houston
- University of Texas MD Anderson Cancer Center, Houston
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
招募中1 期
- MD Anderson Cancer Center, Houston
- NEXT Oncology, Houston
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
招募中
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
招募中3 期
- Houston Methodist Cancer Center, Houston
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
招募中3 期
- Quetzal Site 6, Houston
Intratumoral N17350 in Advanced Solid Tumors
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中3 期
- The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
招募中2 期
- The University of Texas MD Anderson Cancer Center, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- MD Anderson, Houston
Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
招募中觀察性研究
- UT MD Anderson Cancer Center, Houston
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
招募中2/3 期
- The University of Texas Health Science Center at Houston, Houston
- University of Texas- MD Anderson, Houston
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
招募中觀察性研究
- M D Anderson Cancer Center, Houston
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
招募中1/2 期
- University of Texas-MD Anderson Cancer Center ( Site 3007), Houston
Statins to Prevent Cancer Associated Blood Clots
招募中4 期
- The University of Texas MD Anderson Cancer Center, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
招募中2 期
- The University of Texas MD Anderson Cancer Center, Houston
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
招募中2 期
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
招募中1/2 期
- The University of Texas Md Anderson Cancer Center, Houston
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
招募中1/2 期
- Research Site, Houston
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
招募中1 期
- Houston Methodist Hospital ( Site 0103), Houston
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
招募中1/2 期
- NEXT Oncology ( Site 1011), Houston
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
招募中1 期
- Investigational Site Number: 401, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
招募中1 期
- MD Anderson Cancer Center - University of Texas, Houston
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
招募中1 期
- UT MD Anderson, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
招募中1/2 期
- University of Texas MD Anderson Cancer Center, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
招募中2 期
- Kelsey-Seybold Clinic, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
招募中2 期
- M D Anderson Cancer Center, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
招募中1 期
- MD Anderson Cancer Center, Houston
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)
招募中
- The University of Texas M. D. Anderson Cancer Center, Houston
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System
招募中
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- The University of Texas MD Anderson Cancer Center, Houston
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
招募中2 期
- M D Anderson Cancer Center, Houston
ORB-021 In Patients With Advanced Solid Tumors
招募中1 期
- MDAC, Houston
Project: Every Child for Younger Patients With Cancer
招募中觀察性研究
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
招募中3 期
- Houston Metro Urology, Houston
Abatacept in Immune Checkpoint Inhibitor Myocarditis
招募中3 期
- MD Anderson Cancer Center, Houston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer
招募中觀察性研究
- The University of Texas M. D. Anderson Cancer Center, Houston
Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
招募中
- MD Anderson, Houston
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
招募中1 期
- The University of Texas M. D. Anderson Cancer Center, Houston
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
招募中2 期
- The University of Texas M. D. Anderson Cancer Center, Houston
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
招募中
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- The University of Texas, MD Anderson Cancer Center, Houston
Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital
招募中
- The University of Texas M. D. Anderson Cancer Center, Houston
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
招募中2 期
- M D Anderson Cancer Center, Houston
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
招募中2 期
- Texas Childrens Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Houston Methodist Hospital, Houston
- Memorial Hermann Texas Medical Center, Houston
- Methodist Willowbrook Hospital, Houston
- 還有 1 項
IDOV-Immune for Advanced Solid Tumors
招募中1 期
- MD Anderson Cancer Center, Houston
New Assessment System in Measuring Symptom Distress in Cancer Patients
招募中觀察性研究歡迎健康志工
- M D Anderson Cancer Center, Houston
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
招募中2 期
- MD Anderson Cancer Center, Houston
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
招募中歡迎健康志工
- MD Anderson Cancer Center, Houston
Decoupling Immunotherapy Toxicity and Cancer Response
招募中觀察性研究
- The University of Texas M. D. Anderson Cancer Center, Houston
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
招募中3 期
- M D Anderson Cancer Center, Houston
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
招募中
- M D Anderson Cancer Center, Houston
Long-Term Follow-Up of Recipient of Gene Transfer Research
招募中觀察性研究歡迎健康志工
- University of Texas MD Anderson Cancer Center, Houston
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中1 期
- Oncology Consultants /ID# 268323, Houston
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
招募中2 期
- The University of Texas MD Anderson Cancer Center /ID# 273539, Houston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- University of Texas MD Anderson Cancer Center, Houston
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
Molecular Genetics Studies of Cancer Patients and Their Relatives
招募中觀察性研究歡迎健康志工
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
A Multi Center Study of Sexual Toxicities After Radiotherapy
招募中觀察性研究
- M.D. Anderson Cancer Center, Houston
Childhood Cancer Survivor Study
招募中觀察性研究歡迎健康志工
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital, Houston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, Houston
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
招募中1 期
- University of Texas MD Anderson Cancer Center /ID# 252004, Houston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
招募中1 期
- The University of Texas MD Anderson Cancer Center, Houston
Active Living After Cancer: Implementation Within Be Well Acres Homes
招募中
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- MD Anderson Cancer Center, Houston
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
招募中1/2 期
- University of Texas MD Anderson Cancer Center, Houston
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
招募中1 期
- MDACC, Houston
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
招募中2/3 期
- MD Anderson Cancer Centerr, Houston
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma
招募中1/2 期
- M D Anderson Cancer Center, Houston
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
招募中2 期
- The University of Texas MD Anderson Cancer Center, Houston
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
招募中1/2 期
- MD Anderson Cancer Center, Houston
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
招募中2 期
- University of Texas MD Anderson Cancer Center, Houston
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
招募中觀察性研究
- M D Anderson Cancer Center, Houston
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
招募中1 期
- MD Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
招募中2 期
- M D Anderson Cancer Center, Houston
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
招募中觀察性研究
- MD Anderson Cancer Center, Houston
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
招募中1 期
- University of Texas MD Anderson Cancer Center, Houston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
招募中觀察性研究歡迎健康志工
- Grace Clinic, Houston
Suprachoroidal Administration in Subjects With Metastases to the Choroid
招募中2 期
- Retina Consultants of Texas, Bellaire · 距離 7 英里
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
招募中2 期
- Houston Methodist Neal Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
招募中觀察性研究
- Md Anderson Cancer Center, Houston
Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
招募中2 期
- Baylor St. Luke's Medical Center, Houston
- Ben Taub Hospital (Harris Health Systems), Houston
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
招募中
- M D Anderson Cancer Center, Houston
Primary Tumor Research and Outcomes Network
招募中觀察性研究
- The University of Texas M.D. Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
招募中
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study of YL242 in Subjects With Advanced Solid Tumors
招募中1/2 期
- US-203, Houston
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
招募中3 期
- Houston Methodist Neal Cancer Center, Houston
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
招募中1 期
- The University of Texas MD Anderson Cancer Center, Houston
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
招募中觀察性研究
- MD Anderson Cancer Center, Houston
- Texas Children's Hospital, Houston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
招募中2 期
- MD Anderson Cancer Center, Houston
Childhood Cancer Predisposition Study (CCPS)
招募中觀察性研究
- Baylor College of Medicine, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Houston
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
招募中觀察性研究歡迎健康志工
- Oncology Consultants, P.A., Houston
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
招募中
- Baylor College of Medicine- McNair Campus, Houston
- Baylor College of Medicine, Houston
- Ben Taub General Hospital, Houston
- 還有 1 項
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
招募中2 期
- The University of Texas Health Science Center at Houston, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
招募中1 期
- MD Anderson Cancer Center, Houston
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- MD Anderson Cancer Center, Houston
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
Trial of DFP-14927 in Advanced Solid Tumors
招募中1 期
- MD Anderson Cancer Center, Houston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
招募中1/2 期
- Oncology Consultants, P.A., Houston
- The University of Texas M. D. Anderson Cancer Center, Houston
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- The University of Texas MD Anderson Cancer Center, Houston
HPV Vaccine, Imiquimod, and Metformin Combination Trial
招募中2 期
- Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
- Harris Health Smith Clinic, Houston
A Study in Patients With Advanced Cancers
招募中1/2 期
- University of Texas MD Anderson Cancer Center, Houston
其他城市的 癌症（所有類型） 試驗
- New York City, NY109 項研究
- Boston, MA85 項研究
- Los Angeles, CA74 項研究
- Nashville, TN65 項研究
- Philadelphia, PA59 項研究
- Washington, DC58 項研究
- Durham, NC58 項研究
- Chicago, IL51 項研究
- Atlanta, GA49 項研究
- Seattle, WA49 項研究
- Arlington, VA48 項研究
- St. Louis, MO46 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
- 頭頸部鱗狀細胞癌47 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。